| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 [M. R. Wy., M. A. D., A. R., T. S. L.], and Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, Michigan 48824 [M. R. Wi., J. E. T.]
Although considerable attention has been directed in the field of gene therapy toward elucidating the mechanism by which a transduced cell could kill a bystander cell, little is known about how bystander cells may affect transduced cells. We hypothesized that bystander cells, particularly if they were capable of gap junctional communication, could protect cells transduced with the herpes simplex virus thymidine kinase (HSV-TK) from ganciclovir (GCV)-induced cytotoxicity. To test this hypothesis, we used a rat hepatocyte cell line (WB) that can carry out efficient gap junctional communication, a WB clone transduced with HSV-TK (WB-TK), and a communication-incompetent subclone of WB cells (aB1). We cocultured WB-TK cells with either WB or aB1 cells, treated them with GCV, and then plated the cells into selective media that permitted us to quantify independently the surviving fraction of WB-TK cells or bystander cells. We found that WB bystander cells conferred up to a 1000-fold protection on WB-TK cells treated with GCV. aB1 cells conferred detectable, but significantly less, protection. These findings demonstrate that herpes simplex virus thymidine kinase-transduced cells can be significantly protected by bystander cells, particularly those that can carry out gap junctional communication. Whether this "Good Samaritan" effect improves the overall efficacy of gene therapy, by prolonging the survival of the source of toxic metabolites, or decreases effectiveness by increasing the survival of transduced cells will need to be determined in vivo.
1 Supported by NIH Grant PO1 CA42761 (to T. S. L.) and by the National Cancer Institute Grant RO1 CA21104 (to J. E. T.).
2 To whom requests for reprints should be addressed, at Department of Radiation Oncology, University of Michigan, 1331 East Ann, Ann Arbor, MI 48109-0582. Phone: (313) 936-7380; Fax: (313) 763-1581; E-mail: tsl@umich.edu.
Received 10/ 3/96. Accepted 3/ 6/97.
This article has been cited by other articles:
![]() |
M. L. Ramnaraine, W. E. Mathews, J. M. Donohue, C. M. Lynch, M. J. Goblirsch, and D. R. Clohisy Osteoclasts Direct Bystander Killing of Bone Cancer. Cancer Res., November 15, 2006; 66(22): 10929 - 10935. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Gentry, P. D. Boucher, and D. S. Shewach Hydroxyurea Induces Bystander Cytotoxicity in Cocultures of Herpes Simplex Virus Thymidine Kinase-Expressing and Nonexpressing HeLa Cells Incubated with Ganciclovir. Cancer Res., April 1, 2006; 66(7): 3845 - 3851. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Bennett, C. Li, P. W. Allan, W. B. Parker, and S. E. Ealick Structural Basis for Substrate Specificity of Escherichia coli Purine Nucleoside Phosphorylase J. Biol. Chem., November 21, 2003; 278(47): 47110 - 47118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, S. Li, M. K. Nyati, S. DeRemer, J. Parsels, A. Rehemtulla, W. D. Ensminger, and T. S. Lawrence Regional Delivery and Selective Expression of a High-Activity Yeast Cytosine Deaminase in an Intrahepatic Colon Cancer Model Cancer Res., February 1, 2003; 63(3): 658 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Yaoita, J. Yao, Y. Yoshida, T. Morioka, M. Nameta, T. Takata, J.-i. Kamiie, H. Fujinaka, T. Oite, and T. Yamamoto Up-Regulation of Connexin43 in Glomerular Podocytes in Response to Injury Am. J. Pathol., November 1, 2002; 161(5): 1597 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mesnil and H. Yamasaki Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1 Cancer Res., August 1, 2000; 60(15): 3989 - 3999. [Abstract] [Full Text] |
||||
![]() |
D. A. Hamstra, M. Pagé, J. Maybaum, and A. Rehemtulla Expression of Endogenously Activated Secreted or Cell Surface Carboxypeptidase A Sensitizes Tumor Cells to Methotrexate-{{alpha}}-Peptide Prodrugs Cancer Res., February 1, 2000; 60(3): 657 - 665. [Abstract] [Full Text] |
||||
![]() |
L. Z. Rubsam, P. D. Boucher, P. J. Murphy, M. KuKuruga, and D. S. Shewach Cytotoxicity and Accumulation of Ganciclovir Triphosphate in Bystander Cells Cocultured with Herpes Simplex Virus Type 1 Thymidine Kinase-expressing Human Glioblastoma Cells Cancer Res., February 1, 1999; 59(3): 669 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Carystinos, M. M. Katabi, D. W. Laird, J. Galipeau, H. Chan, M. A. Alaoui-Jamali, and G. Batist Cyclic-AMP Induction of Gap Junctional Intercellular Communication Increases Bystander Effect in Suicide Gene Therapy Clin. Cancer Res., January 1, 1999; 5(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Hughes, S. A. King, P. W. Allan, W. B. Parker, and E. J. Sorscher Cell to Cell Contact Is Not Required for Bystander Cell Killing by Escherichia coli Purine Nucleoside Phosphorylase J. Biol. Chem., January 23, 1998; 273(4): 2322 - 2328. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Azzam, S. M. de Toledo, and J. B. Little Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells PNAS, January 16, 2001; 98(2): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |